Cardiovascular complications following the receipt of mRNA-based (Pfizer-BioNTech and
Moderna) coronavirus disease 2019 (COVID-19) vaccines have not yet been described. In …

After the surging rise in the Coronavirus disease 2019 (COVID-19) pandemic, the Food and
Drug Administration (FDA) approved emergency approval of vaccinations to prevent life …

Since June 2021, cases of myocarditis after the BNT162b2 vaccine (Pfizer/BioNTech) have
been reported, mainly in young men after the second dose of the vaccine. 1 A report from …

Myocarditis and pericarditis after vaccination for COVID‐19 - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

Background and aims Recent media reports of myocarditis after receiving COVID-19
vaccines, particularly the messenger RNA (mRNA) vaccines, are causing public concern …

Background Cases of myocarditis and myopericarditis after mRNA COVID-19 vaccines have
been reported, especially after the second dose and in young males. Their course is …

Messenger RNA vaccines are the main COVID-19 vaccines authorized for use in the United
States. Side effects are typically minor and transient. We report a case series of four subjects …

Vaccination plays an important role in the fight against SARS-CoV-2 to minimie the spread
of coronavirus disease 2019 (COVID-19) and its life-threatening complications. Myocarditis …

Abstract Background The SARS-CoV-2 pandemic has led to the development of the first
mRNA vaccines used in humans. The vaccines are well tolerated, safe, and highly …

Myocarditis is an inflammatory cardiomyopathy, most frequently caused by viral agents,
affecting 10-20 individuals per 100.000 each year in the general population [1]. Myocarditis …